Table 4.

Trials showing the outcome of posttransplant immunoglobulin A nephropathy

Author(s)	Year	Recurrence number	Follow-up (mean)	Results (patients with recurrence)
Kessler et al.[10]	1998	13	68.1±37.2 months	Similar 1-, 5-, and 8-year graft survival and serum creatinine
Frohnert et al.[11]	1997	13	>10 years	71% graft failure
Ohmacht et al.[12]	1997	14	51 months	71% graft failure
Matsugami et al.[27]	1998	12	—	68.8% graft loss at 10 years
Freese et al.[14]	1999	13	60 months (median)	46.1% graft failure at 5 years
Kim et al.[4]	2001	19	—	Similar graft survival at 10 years
Wang et al.[15]	2001	14	55 months	Graft dysfunction in 29% at 5 years
Andresdottir et al.[5]	2001	7	5.6±4.5 years	Similar estimated 10-year survival
Choy et al.[7]	2003	14	100±4.5 months	35.7% graft failure
Jeong et al.[28]	2004	39		10-year graft survival of 66.5% (comparable)
Moriyama et al.[29]	2005	13	10 years	Graft failure in 38.5% vs. 9.2%
Chandrakantan et al.[16]	2005	20	—	10-year graft survival of 50% vs. 80%
Pazik et al.[30]	2006	27	61 months	6.57 times higher risk of graft failure
Han et al.[18]	2009	68	10 years	61% graft survival vs. 85.1%
Kamal et al.[31]	2012	25	6.6 years	Comparable graft survival
Moroni et al.[32]	2012	42	113.1 months	Death-censored graft survival of 51.2% vs. 68.3%
Lemes-Canuto et al.[33]	2015	128	—	58.5% graft survival at 10 years
Nijim et al.[34]	2016	23	—	Mean graft survival 6.5±5.1 years (vs. 10.5±3.5 years)
Kim et al.[35]	2017	15	82.5 months	73% graft failure
Cordeiro et al.[36]	2018	47	>6 months after IgAN recurrence	31.9% graft loss
Current study	2021	51	84.2 months	10-year graft survival of 44.6% and death-censored graft survival of 59%